SEI Investments’s Insys Therapeutics, Inc. INSY Stock Holding History

SEI Investments’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6	Closed	–	–	3782
2017 Q4	$0	Buy	+6	New	+$39	﹤0.01%	3597
2016 Q2	–	Sell	-80,924	Closed	-$1.29M	–	2816
2016 Q1	$1.29M	Buy	80,924 +1,979	+3%	+$37.6K	0.01%	1086
2015 Q4	$2.26M	Buy	78,945 +4,854	+7%	+$134K	0.01%	957
2015 Q3	$2.11M	Buy	74,091 +27,518	+59%	+$1.01M	0.02%	781
2015 Q2	$1.67M	Sell	46,573 -4,943	-10%	-$154K	0.02%	809
2015 Q1	$1.5M	Buy	51,516 +2,888	+6%	+$76.4K	0.01%	833
2014 Q4	$1.02M	Buy	+48,628	New	+$962K	0.01%	936

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SEI Investments's INSY Position: Q1 2018 in Review

SEI Investments sold out of Insys Therapeutics, Inc. (INSY) in Q1 2018, closing a stake of 6 shares.

SEI Investments first reported a position in INSY in Q4 2014 and held it in 7 quarters. The position peaked at $2.26M in Q4 2015. 110 funds tracked by Wall St. Rank hold INSY as of Q1 2018.

SEI Investments reported no remaining Insys Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
SEI Investments sold 6 Insys Therapeutics, Inc. shares in Q1 2018.
SEI Investments first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 7 quarters.
SEI Investments's Insys Therapeutics, Inc. position peaked at $2.26M in Q4 2015.
110 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2018.

Based on SEI Investments's 13F filing for Q1 2018, filed 11 May 2018.